Loading...
Preeclampsia, which affects 4% of U.S. pregnancies, can contribute significantly to maternal and neonatal morbidity and mortality if not detected early and managed effectively. Screening for preeclampsia generally includes blood pressure monitoring during pregnancy, with additional urine and serum laboratory evaluations as needed. The U.S. Preventive Services Task Force (USPSTF) recently reviewed the evidence for preeclampsia screening during pregnancy.
Recognizing the burden of disease and its capacity to evolve quickly, the USPSTF concluded with moderate certainty, based on the available evidence, that preeclampsia screening with blood pressure measurement during pregnancy provides benefit without significant harm. Testing for urinary excr…